Premier Clinical Research, Inc. — Form D

Premier Clinical Research, Inc. of SPRINGBORO, OH, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-15. The offering totals $5.2M, of which $10K was reported sold. Industry: Other Health Care.

Offering

• Filed: 2023-11-15
• Form: D
• Accession: 0002001008-23-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $5.2M
• Amount sold: $10K
• Remaining: $5.2M
• Minimum investment: $10K
• Investors: 1
• Date of first sale: 2023-11-01
• Security types: equity
• Revenue range: $1,000,001 - $5,000,000
• SEC file number: 021-497250

Issuer

• Name: Premier Clinical Research, Inc.
• CIK: 0002001008
• Entity type: Corporation
• Jurisdiction: OHIO
• Incorporated: 2023
• Address: 66 REMICK BOULEVARD, SPRINGBORO, OH, 45066
• Phone: 937-930-4050

Officers, directors & promoters (8)

More

• CIK 2001008 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search